United Laboratories International Holdings Ltd
HKEX:3933
Intrinsic Value
United Laboratories International Holdings Ltd. is an investment company, which engages in the research, development, production and operation of medical intermediates, active pharmaceutical ingredien... [ Read More ]
The intrinsic value of one United Laboratories International Holdings Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 9.48 HKD, United Laboratories International Holdings Ltd is hidden .
Valuation Backtest
United Laboratories International Holdings Ltd
Run backtest to discover the historical profit from buying and selling United Laboratories International Holdings Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
United Laboratories International Holdings Ltd
| Current Assets | 13.8B |
| Cash & Short-Term Investments | 4.3B |
| Receivables | 6.3B |
| Other Current Assets | 3.2B |
| Non-Current Assets | 7.2B |
| Long-Term Investments | 7.8m |
| PP&E | 7B |
| Intangibles | 137m |
| Other Non-Current Assets | 80.8m |
| Current Liabilities | 6.6B |
| Accounts Payable | 6.1B |
| Other Current Liabilities | 574.1m |
| Non-Current Liabilities | 1.7B |
| Long-Term Debt | 1.3B |
| Other Non-Current Liabilities | 352.3m |
Earnings Waterfall
United Laboratories International Holdings Ltd
|
Revenue
|
13.7B
CNY
|
|
Cost of Revenue
|
-7.4B
CNY
|
|
Gross Profit
|
6.3B
CNY
|
|
Operating Expenses
|
-3.1B
CNY
|
|
Operating Income
|
3.3B
CNY
|
|
Other Expenses
|
-580.4m
CNY
|
|
Net Income
|
2.7B
CNY
|
Free Cash Flow Analysis
United Laboratories International Holdings Ltd
Profitability Score
Profitability Due Diligence
United Laboratories International Holdings Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
United Laboratories International Holdings Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
United Laboratories International Holdings Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
United Laboratories International Holdings Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
United Laboratories International Holdings Ltd
According to Wall Street analysts, the average 1-year price target for United Laboratories International Holdings Ltd is 12.74 HKD with a low forecast of 9.03 HKD and a high forecast of 23.1 HKD.
Shareholder Return
Price
United Laboratories International Holdings Ltd
| Average Annual Return | 8.26% |
| Standard Deviation of Annual Returns | 20.3% |
| Max Drawdown | -63% |
| Market Capitalization | 17.2B HKD |
| Shares Outstanding | 1 817 026 508 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
United Laboratories International Holdings Ltd. is an investment company, which engages in the research, development, production and operation of medical intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical preparations. The firm operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
Contact
IPO
Employees
Officers
The intrinsic value of one United Laboratories International Holdings Ltd stock under the Base Case scenario is hidden HKD.
Compared to the current market price of 9.48 HKD, United Laboratories International Holdings Ltd is hidden .
You don't have any saved screeners yet
